Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Market Insights
Regulatory Landscape
Patent Review
Product Recalls
Product Pipeline

Chapter 3 Market Dynamics
Market Dynamics Snapshot
Drivers
Wide Range of Potential Applications of Combinations Products
Growing Prevalence of Chronic Diseases
Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
Restraints
Device Reliability and Robustness
Human Factors Testing
Drug and Device Integration
Accommodating Different Volumes
Challenges
Biological Safety Challenges in Drug-Device Combinations
Regulatory Challenges
Opportunities
Technology advancements and Innovative Product Launches
Continuous Growth
Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market

Chapter 4 Market Segmentation Analysis
Segmentation Breakdown
Drug-Device Combinations Market by Product Type
Drug/Biologic-Device Combination Products
Drug-Biologic Drug-Device Combination Products
Drug, Device and Biologic Combination Products
Drug-Device Combinations Market by Application
Cardiovascular Diseases
Metabolic Disorders
Respiratory Diseases
Wound Care
Oncology
Orthopedic Conditions
Others
Geographic Breakdown
Drug-Device Combinations Market, by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 5 Emerging Trends and Technologies
Overview
AI in Drug-Device Combination
Nanotechnology
Computational Models and Simulation
Human Organs-on-Chips: Revolutionizing Medical Research
Implantable Drug Delivery Systems
Wireless Implants
Smart Drug Delivery Devices for 3D Printing
Recent Approvals and Launch of Novel Drug-device Combination Products

Chapter 6 ESG Development
Introduction
ESG Sustainability in Drug-Device Combinations Market
ESG Risk Ratings
WHO Guidelines and Global Initiatives

Chapter 7 Competitive Landscape
Company Share Analysis
Mergers, Acquisitions and Collaborations
Strategic Alliances

Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
3M
ABBOTT
B. BRAUN SE
BD
BOSTON SCIENTIFIC CORP.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC
SMITH+NEPHEW
STRYKER
TERUMO CORP.



List of Figures

 

Summary Figure : Global Market for Drug-Device Combinations, by Product Type, 2021–2029
Figure 1 : U.S. FDA Combination Product Approval Pathway
Figure 2 : Snapshot of the Global Markets for Drug-Device Combinations
Figure 3 : Share of New Cancer Cases (Incidence) Globally, by Region, 2022
Figure 4 : Share of Cancer Mortality Cases Globally, by Region, 2022
Figure 5 : Global Market Shares of Drug-Device Combination Products, by Product Type, 2023
Figure 6 : Global Market for Drug-Device Combination Products, by Region, 2021–2029
Figure 7 : Global Market Shares of Drug-Device Combination Products, by Region, 2023
Figure 8 : Traditional and New Generation Drug-Device Combination
Figure 9 : Global Market Shares of Drug-Device Combination Products, by Company, 2023
Figure 10 : 3M: Revenue Share, by Country/Region, FY 2023
Figure 11 : 3M: Revenue Share, by Business Unit, FY 2023
Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023
Figure 13 : Abbott: Revenue Share, by Business Unit, FY 2023
Figure 14 : B Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 15 : B Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 16 : BD: Revenue Share, by Country/Region, FY 2023
Figure 17 : BD: Revenue Share, by Business Unit, FY 2023
Figure 18 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023
Figure 19 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023
Figure 20 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023
Figure 21 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023
Figure 22 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 23 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 24 : Smith+Nephew: Revenue Share, by Country/Region, FY 2023
Figure 25 : Smith+Nephew: Revenue Share, by Business Unit, FY 2023
Figure 26 : Stryker: Revenue Share, by Country/Region, FY 2023
Figure 27 : Stryker: Revenue Share, by Business Unit, FY 2023
Figure 28 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 29 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023

List of Tables


Summary Table : Global Market for Drug-Device Combinations, by Product Type, Through 2029
Table 1 : EU Combination Product Regulation
Table 2 : Granted Patents on Drug-Device Combination Products in 2024, U.S.
Table 3 : Recalled Drug-Device Combination Products, 2021–2024
Table 4 : Drug-Device Combination Product Pipeline
Table 5 : Projected Number of Adults 50 Years and Older With ?1 Chronic Condition in the United States, 2020–2050
Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2029
Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029
Table 8 : Global Market for Drug Eluting Stents (DES), by Region, Through 2029
Table 9 : Marketed or Late-stage Development Products in DCDs
Table 10 : Global Market for Prefilled Syringe (PFS), by Region, Through 2029
Table 11 : Global Market for Inhalers, by Region, Through 2029
Table 12 : Global Market for Nebulizers, by Region, Through 2029
Table 13 : Global Market for Wound Care Products, by Region, Through 2029
Table 14 : Global Market for Implants, by Region, Through 2029
Table 15 : Available Catheter Types in Clinical Use, 2022
Table 16 : Global Market for Antimicrobial Catheters, by Region, Through 2029
Table 17 : Global Market for Transdermal Patches, by Region, Through 2029
Table 18 : Global Market for Photodynamic Therapy (PDT), by Region, Through 2029
Table 19 : Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029
Table 20 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029
Table 21 : FDA Approved ADCs
Table 22 : Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029
Table 23 : Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029
Table 24 : Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029
Table 25 : Global Market for Drug-Device Combination Products, by Application, Through 2029
Table 26 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029
Table 27 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029
Table 28 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029
Table 29 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029
Table 30 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029
Table 31 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029
Table 32 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029
Table 33 : Global Market for Drug-Device Combination Products, by Region, Through 2029
Table 34 : North American Market for Drug-Device Combination Products, by Country, Through 2029
Table 35 : European Market for Drug-Device Combination Products, by Country, Through 2029
Table 36 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029
Table 37 : ESG Highlights, by Major Players, 2023
Table 38 : ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023
Table 39 : Market Players and the Products They Offer for Various Applications
Table 40 : Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021–2024
Table 41 : Major Strategic Alliances in the Drug-Device Combination Industry, 2021–2024
Table 42 : Information Sources in this Report
Table 43 : Major Abbreviations Used in This Report
Table 44 : 3M: Company Snapshot
Table 45 : 3M: Financial Performance, FY 2022 and 2023
Table 46 : 3M: Products Portfolio
Table 47 : 3M: News/Key Developments, 2023
Table 48 : Abbott: Company Snapshot
Table 49 : Abbott: Financial Performance, FY 2022 and 2023
Table 50 : Abbott: Products Portfolio
Table 51 : Abbott: News/Key Developments, 2024
Table 52 : B Braun SE: Company Snapshot
Table 53 : B Braun SE: Financial Performance, FY 2022 and 2023
Table 54 : B. Braun SE: Products Portfolio
Table 55 : B. Braun SE: News/Key Developments, 2022
Table 56 : BD: Company Snapshot
Table 57 : BD: Financial Performance, FY 2022 and 2023
Table 58 : BD: Product Portfolio
Table 59 : BD: News/Key Developments, 2023
Table 60 : Boston Scientific Corp.: Company Snapshot
Table 61 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 62 : Boston Scientific Corp.: Products Portfolio
Table 63 : Boston Scientific Corp.: News/Key Developments, 2024
Table 64 : Johnson & Johnson Services Inc.: Company Snapshot
Table 65 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023
Table 66 : Johnson & Johnson Services Inc.: Product Portfolio
Table 67 : Johnson & Johnson Services Inc.: News/Key Developments, 2022
Table 68 : Medtronic: Company Snapshot
Table 69 : Medtronic: Financial Performance, FY 2022 and 2023
Table 70 : Medtronic: Products Portfolio
Table 71 : Medtronic: News/Key Developments, 2024
Table 72 : Smith+Nephew: Company Snapshot
Table 73 : Smith+Nephew: Financial Performance, FY 2022 and 2023
Table 74 : Smith+Nephew: Products Portfolio
Table 75 : Smith+Nephew: News/Key Developments, 2024
Table 76 : Stryker: Company Snapshot
Table 77 : Stryker: Financial Performance, FY 2022 and 2023
Table 78 : Stryker: Products Portfolio
Table 79 : Terumo Corp.: Company Snapshot
Table 80 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 81 : Terumo Corp.: Product Portfolio
Table 82 : Terumo Corp.: News/Key Developments, 2023